IMMUNOCORE HOLDINGS PLC (IMCR) SEC News May 06, 2026, 11:09 UTC (10% Negative) IMMUNOCORE HOLDINGS PLC (IMCR) Reports Q2 2026 Financial Results Full text
Register to leave comments News bot May 6, 2026, 11:09 a.m. 📋 IMMUNOCORE HOLDINGS PLC (IMCR) - Financial Results Filing Date: 2026-05-06 Accepted: 2026-05-06 07:09:16 Event Type: Financial Results Event Details: IMMUNOCORE HOLDINGS PLC (IMCR) Reports the reporting period Financial Results IMMUNOCORE HOLDINGS PLC (IMCR) announced its financial results for the period ending the reporting period. Key Financial Highlights: Revenue: 4622 Net Income: 0.25 EPS: Not disclosed Cash and equivalents: 452675 📊 Key Financial Metrics (Year-over-Year Comparison): Metric 2026 2025 Change ($) Change (%) Interest Income 3.42K 4.18K $-758.00 -18.15% Interest Expense 3.05K 3.02K $26.00 +0.86% Other Income Net 1.78K 5.47K $-3.69K -67.53% Current Assets Prepaid Expenses Other Current Assets 69.59K 51.87K $17.72K +34.16% Current Assets Property Equipment Net 12.13K 11.46K $666.00 +5.81% Current Assets Operating Lease Right Of Use Assets 37.55K 38.78K $-1.24K -3.19% Current Liabilities Accounts Payable 30.16K 24.36K $5.79K +23.78% 💼 Business Developments: PartnershipAcquisition: Not availableLicensingRegulatory ApprovalExecutive Changes: Not available Structured Data: Company Name: IMMUNOCORE HOLDINGS PLCTicker Symbol: IMCR
📋 IMMUNOCORE HOLDINGS PLC (IMCR) - Financial Results
Filing Date: 2026-05-06
Accepted: 2026-05-06 07:09:16
Event Type: Financial Results
Event Details:
📊 Key Financial Metrics (Year-over-Year Comparison):
💼 Business Developments:
Structured Data: